Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech

Frontotemporal Dementia (FTD) encompasses a range of progressive neurodegenerative conditions that impair speech production and comprehension, higher cognitive functions, behavior, and motor skills. Considerable research has focused on conventional acoustic speech markers in FTD, as well as assessments of apathy and challenges in emotion recognition and expression.

In this study, Redenlab has collaborated with the University of Melbourne, Monash University, and the Massachusetts Institute of Technology.

For more information about the study, please click here.

Related Post

  • Posted on 18 February, 2025
    Batten disease, or neuronal ceroid lipofuscinosis (NCL), is a devastating childhood dementia that causes progressive loss of speech, language, and...
    • Posted on 18 February, 2025
      Redenlab is dedicated to advancing research in the field of speech, language, and cognitive disorders, particularly in the context of...
      • Posted on 28 January, 2025
        Researchers at University of Texas at Austin have developed a behavioral therapy designed to improve communication in individuals with primary...